drugset / Trial / NCT02041273
Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions
NaSingle-groupOpen-labelBasic science
Summary
A relative bioavailability study of commercial palbociclib free base hard capsules to the isethionate salt palbociclib capsules ( used in Phase 1 and 2 studies) under different fasting conditions.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palbociclib | Small molecule | 125 mg | — |
Indications
No indication recorded.